ABSTRACT-Effects of phellodendrine (OB-5) on crescentic-type anti-GBM nephritis in rats and the cell number of the various leukocyte subpopulations in the glomeruli of the nephritic rats were investi gated. OB-5 at 25, 50 and 100 mg/kg/day, p.o. prevented the urinary protein excretion by the 19th day after i.v.-injection of anti-GBM serum. In the OB-5-treated rats, plasma cholesterol and creatinine con tents were lower than those of the control rats throughout the 40-day experimental period. Histopatho logical observations demonstrated that OB-5 inhibited the incidence of crescent formation, adhesion and fibrinoid necrosis in the glomeruli by the 41st day. OB-5 did not affect the plasma antibody titer against rabbit gamma globulin. The increases in total leukocytes, macrophages, cytotoxic/suppressor T cells, la positive cells, and IL-2 receptor positive cells in the glomeruli in OB-5, 100 mg/kg-treated rats as well as those of the animals treated with azathioprine or cyclosporin A were lower than those of the anti-GBM nephritic control. These results indicate that OB-5 was effective in crescentic-type anti-GBM nephritis and the antinephritic mechanisms of this agent may be due to its ability to inhibit the prolifera tion or the migration of macrophages and cytotoxic T lymphocytes in the glomeruli.
Of the crude drugs, Phellodendri Cortex obtained from Phellodendron amurense RuPR (Rutaceae) has been prescribed in many Japanese herbal medicines, and it has been widely accepted that Phellodendri Cor tex exerts stomachic effects. Recent investigations have demonstrated the innovative actions of components, which are included in Phellodendri Cortex. It has been demonstrated that components isolated from Phel lodendri Cortex could exhibit the anti-inflammatory ac tion against carrageenin-induced paw edema in rats (1) .
Moreover, Koda (2) documented in mice that of the components, phellodendrine (OB-5) markedly inhibited the local graft versus host reaction (GvHR). It has been considered that its action of OB-5 may be mainly re stricted to effector cells. These findings suggest that phellodendrine may have inhibitory effects against chro nic inflammatory or delayed type hypersensitivity.
It has been generally accepted that the induction and development of glomerulonephritis is mediated by im munological events. In addition, the infiltration of various leukocyte subpopulations into the glomeruli has been observed, and human and animal studies have suggested that these cells are involved in the glomerular damages (3) (4) (5) . Accordingly, there is much evidence indicating that local cellular immune activation may be associated with the immunopathogenesis of glomerulo nephritis (3 6) .
Original-type anti-GBM nephritis is characterized by moderate proteinuria and mild proliferation of glomeru lar cells. A previous study (7) demonstrated that OB-5 inhibited the urinary protein excretion in original-type anti-GBM nephritis. However, the antinephritic mecha nisms of OB-5 on glomerulonephritis are still unclear.
To elucidate the antinephritic actions and mecha nisms of OB-5 in an experimental model of rapidly progressive glomerulonephritis, we investigated the effects of OB-5 on crescentic-type anti-GBM nephritis, which has more severe proteinuria and proliferation of glomerular cells than those of the original-type model (8) . In addition, we undertook studies utilizing mono clonal antibody against total leukocytes (OX-1), macro phages (ED-1), cytotoxic/suppressor T cell (OX-8), la positive cells (RT1B) and IL-2 positive cells (OX-39) to detect the effect of OB-5 on the number of these cells in the glomeruli of nephritic rats.
MATERIALS AND METHODS

Amimals
Male Sprague-Dawley strain rats, weighing approx. 160 g (Nihon SLC), were used for all experiments. They were housed in groups of four to five under a 12 hr light-dark cycle with food and water freely available.
Drugs
The chemical structure of phellodendrine (OB-5) (Tsumura Co., Ltd., Tokyo) is shown in Fig. 1 Induction of crescentic-type anti-GBM nephritis Crescentic-type anti-GBM nephritis was inducted by immunizing rats that had received a nephritogenic dose of rabbit anti-rat GBM (anti-GBM) serum with rabbit y globulin (rgG) according to a slight modification of the previously reported method (8) . Fifty rats weighing approx. 160 g were administered 0.75 ml/animal of anti GBM serum into the tail vein. On the day after the in jection of anti-GBM serum, 24-hr urine samples were collected, and the rats were then divided into 5 groups of 8 rats, so that the average protein content in the 24-hr urine in each group was at the same level. After grouping, these animals, were injected with 6.5 mg of rgG in 0.25 ml of Freund's complete adjuvant (FCA) into the hind foot pads.
Evaluation of antinephritic effects of test drugs
Three groups were orally given 25, 15 and 100 mg/kg of OB-5, respectively in a volume of 1 ml per 100 mg of body weight, daily from the day after anti-serum injec tion (the 1st day) to the 41st day. The remaining group was orally given the vehicle (distilled water) instead of test drugs and served as the control. In addition, a non treated (normal) group was used for comparison with the nephritic groups.
Urine and blood collections
The 24-hr urine samples were obtained by keeping each animal in an individual metabolic cage for 24 hr. At the beginning of the urine collection, each animal received 8 ml of distilled water orally without feeding. The urine was then centrifuged at 3,000 rpm for 10 min and the supernatant was used for determination of pro tein. Immediately after the urine collection, 0.4 ml of blood was drawn from tail vein of each conscious ani mal with a disposable syringe and put into a tube con taining 0.025 ml of heparin. The blood was centrifuged at 5,000 rpm to obtain plasma for the determination of cholesterol and creatinine contents.
Determination of urinary protein, plasma cholesterol and creatinine contents
The urinary protein excretion was determined by the method of Kingsbury et al. (9) and expressed as mg/day. The cholesterol content was determined in accordance with the method of Zurkowski (10) and ex pressed as mg/dl plasma. The creatinine content was determined by a creatinine determination kit (CRE EN, Kainos, Inc., Tokyo).
Measurement of plasma antibody titer against rgG
The plasma antibody titer against rgG was deter mined by indirect hemagglutination using sensitized sheep red blood cells (11) .
Assessment of histopathological parameters
For light microscopic study, kidneys were isolated from rats anesthetized with pentobarbital, then dehy drated and fixed by immersing the tissues stepwise into various concentrations of ethyl alcohol from low to high. The tissues were then embedded in paraffin and sectioned into 2 to 3-,um-thick slices. In the studies of crescentic-type nephritis, the sections were stained with hematoxylin and eosin and Masson's trichrome. The crescent formation, adhesion of Bowman's capsule to capillary walls (adhesion) and fibrinoid necrosis in glomeruli was observed under a light microscope. For assessing these parameters, an equatorial cross section was selected by random sampling methods. Fifty glomeruli per section were observed, and the appear ance rate of crescent formation, adhesion and fibrinoid necrosis was expressed as the percentages of glomeruli (incidence) having these morphological alterations. All the above observations were performed blindly on coded sections.
Evaluation of the effects of OB-5 on the changes in the number of leukocyte-subsets in glomeruli of crescentic type anti-GBM nephritis
To evaluate the effects of OB-5, azathioprine and cyclosporin A on the number of leukocyte-subsets in glomeruli of crescentic-type anti-GBM nephritis, these drugs were given p.o. daily to groups of rats after anti GBM serum injection. The control rats were given p.o. the vehicles instead of test drugs. The blood and kid neys of animals in the drug-treated and control groups were taken 2.0 hr after the treatment with the respec tive drugs, under pentobarbital anesthesia, on the 1st, 5th and 15th days after anti-GBM serum injection. Tissues for immunoenzymatic staining were frozen in liquid nitrogen as described below.
Immunohistochemistry
Tissues for immunoenzymatic staining were fixed in paraformaldehyde-lysine-periodate (12) . Serial cryostat sections were adhered to microscope slides, air dried and preincubated with 1-2% nomal horse serum in phosphate-buffered saline (PBS) for 20 min. The sec tions were then incubated with mouse anti-rat mono clonal antibodies for 90 min, washed twice in PBS, treated with 0.3% hydrogen peroxide in methanol for 40 min to block endogenous peroxidase, and incubated with biotinated affinity purified anti-Mouse IgG and avidinated horseradish peroxidase with diaminoben zidine tetrahydrochloride (Vecta stain ABC Kit, Vector Burlingame, CA). All steps were carried out at room temperature.
Monoclonal antibodies
Monoclonal antibodies used in this study were as fol lows: OX-1 (leukocyte common antigen), W3/25 (helper/helper inducer T cells), ED-1 (most macro phages and some dendritic cells), OX-8 (cytotoxic/ suppressor T cell), OX-39 (IL-2 receptor positive cells) and OX-18 (Ia positive cells).
Quantification of leukocytes on tissue sections
Labelled cells within each glomerulus were counted with an image analyzer (TOYOBO VI, Toyobo Co., Ltd., Tokyo), and the results were expressed as the number of cells per glomerular cross section (13) . Cell counts were performed three times to reduce counting errors.
Statistical analyses
The data represent the mean ± S.D., and the results were statistically evaluated by one way analysis of variance with Student's t-test. The inhibitory percentage was calculated as follows:
Inhibitory percentage (%) _ (Control Test drugs) X 100/(Control Normal)
RESULTS
Effects of OB-5 on crescentic-type anti-GBM nephritis General condition and body weight (data not shown): No rats given OB-5 died during the 40-day ex perimental period. A similar amount of rat chow was consumed by both the control and OB-5 groups. In addition, none of the rats given OB-5 exhibited any abnormal behavior or diarrhea. The control and OB-5 groups had lower body weights than that of the normal group throughout the experimental periods. Both con trol and OB-5-treated rats showed a similar course of weight gain.
Urinary protein excretion ( Fig. 2) : From the 10th day after i.v.-injection of anti-GBM serum, the urinary pro tein excretion of control rats markedly increased. OB-5 at 100 mg/kg/day, p.o. had inhibited urinary protein excretion by the 19th day after the anti-GBM serum in jection. In addition, OB-5 at dose of 25 and 50 mg/kg/day, p.o. had also inhibited the excretion by the 29th day. These effects were maintained until the end of the experimental schedule.
Plasma cholesterol and creatinine contents (Figs. 3 and 4): The plasma cholesterol and creatinine contents were determined on the 26th, 34th and 40th days. The plasma cholesterol contents in the control rats were markedly elevated from the 26th to the 40th day (Fig.  3) . In contrast, OB-5 at all doses inhibited the elevation of the cholesterol content with an inhibitory percentage of 68% and 87% on the 34th and the 40th days, respec tively. The plasma creatinine contents in the control rats were also elevated from the 26th to the 40th days (Fig. 4) . On the other hand, in the OB-5, 100 mg/kg/day-treated rats, the plasma creatinine content was similar to that of normal rats on the 40th day.
Plasma antibody titer against rgG (data not shown): The plasma antibody titer against rgG was not affected by OB-5 during the experimental period. mg/kg/day or 100 mg/kg/day-treated rats was less than those of the nephritic control rats. The incidence of crescent formation in OB-5-treated rats had been re duced with an inhibitory percentage of approx. 70%; adhesion, approx. 20% to 50%; and fibrinoid, approx. 30% to 80%. Effects of OB-5 on the cell number of the leukocyte sub population in the glomeruli (Fig. 6 ) The experiments were performed using cyclosporin A and azathioprine as positive control drugs. When the effects of azathioprine and cyclosporin A on crescentic type anti-GBM nephritis were measured on the 20th day after the injection of anti-GBM serum, both drugs significantly reduced urinary protein excretion (Normal: 5.9 ± 2.9 mg/day; Control: 249.6 ± 68.3 mg/day; Aza thioprine: 168.6 ± 77.6 mg/kg, P < 0.01 vs. Control; cyclosporin A: 50.5 ± 35.7 mg/kg, P < 0.01 vs. Con trol). The number of total leukocytes in the control had been significantly increased by the 15th day after the in groups, how ever, the numbers of these cells did not increase during the experimental period, and their levels were normal on the 15th day. The glomeruli in control rats showed a significantly increased number of IL-2 receptor-positive cells on the 5th and the 15th days after the injection of anti-GBM serum. OB-5 or cyclosporin A-treated rats showed a markedly suppressed number of the cells on both the 5th and the 15th days compared with the con trol rats. Azathioprine had not prevented the increase of the number of the cells by the 5th day.
DISCUSSION
In the previous paper, we demonstrated the anti nephritic effect of OB-5 at 50 mg/kg, but not 10 and 20 mg/kg by intraperitoneal administration (7). We under took further experiments to elucidate the antinephritic effect of OB-5 by oral administration and to obtain the dose-dependent effect of OB-5 using 25, 50, and 100 mg/kg. Furthermore, to elucidate the mechanisms of the antinephritic effect of OB-5 in detail, we investi gated the effect of OB-5 on various subsets of mono nuclear cells in nephritic glomeruli. Although the pres ent study has demonstrated that OB-5 significantly pre vents the development of crescentic-type anti-GBM nephritis by oral administration, the effects of OB-5 were not dose-dependent. OB-5 itself is detected in vivo at a very low level compared to the metabolite of OB-5 (personal communication from Tsumura Co.). Therefore, there may be a limit to the uptake of OB-5 in vivo.
In addition, we have also shown that daily OB-5 treatment decreases the number of leukocyte sub populations in the glomeruli of the nephritic rats. The cell-mediated immunity may be induced by localized reactions to organisms, usually intracellular pathogens, mediated by lymphocyted and phagocytes rather than by antibody. Recently, it has been demonstrated that the infiltration of activated mononuclear cells into the glomeruli or cortical tubulointerstitium arise and de layed hypersensitive reactions may be associated with renal injury in glomerulonephritis (3) (4) (5) 14) . A cell transfer study (15) demonstrated that proliferative glomerulonephritis developed with a significant macro phage accumulation and proteinuria, when peritoneal mononuclear inflammatory cells were injected intra venously to leukocyte-depleted rabbits that had already received anti-GBM serum. Recently, Li et al. (16) have reported that IL-2 receptor-positive cells and macrophages in the glomeruli are closely associated with decreased renal function in IgA nephritis with crescent formation. Moreover, Schreiner et al. (17) demonostrated that enhanced la expression in nephro toxic nephritis was seen during proteinuria, and decom plementation prior to anti-GBM serum administration abrogates both the proteinuria and the increased la ex pression, although an increase in cells expressing leuko cyte common antigen still occurred. These findings sug gest that activated macrophages and T lymphocytes in glomeruli may be directly associated with function in proliferative glomerulonephritis.
The present study indicated that the number of macro phages, la-positive cells and cytotoxic T cells in the glomeruli of nephritic control rats were markedly in creased on the 15th day after i.v.-injection of anti serum. The plasma antibody titer against rgG in control rats was also elevated on the same day (unpublished data of T. Hattori). These results suggest that the cell mediated immunity system in addition to the humoral immunity system also may be partly associated with the progression of crescentic-type nephritis. Furthermore, we performed a time-course experiment on the glo merular mononuclear leukocyte subset both in original type and crescentic-type anti-GBM nephritis (unpub lished data of T. Hattori et al.) . Consequently, we found that the accumulation of mononuclear cells in nephritic glomeruli reached the maximum on the 15th day after the injection of anti-GBM serum, then grad ually diminished. We considered that the difference in severity of glomerulonephritis between original and crescentic-type anti-GBM nephritis can be attributed to the difference of the accumulation of mononuclear leukocytes into the glomeruli. Additionally, OB-5 re vealed its antinephritic effect on crescentic-type anti GBM nephritis from the 19th day after the injection of anti-GBM serum. Therefore, we considered that the ex periments on glomerular leukocytes had to be per formed before the 19th day following the anti-GBM serum injection to elucidate whether the suppressive effects of OB-5 on accumulation of glomerular leuko cytes were the cause or the results for the antinephritic effect of OB-5 on crescentic-type anti-GBM nephritis. IL-2 receptor expression is widely accepted marker of immune activation, and it can be anticipated that such cells are functionally acitive within the tissue. It has been reported that IL-2 receptors are expressed not only the surface of helper T cells, but also macrophages and cytotoxic T cells (18, 19) . In addition, IL-2 induces not only the proliferation of helper T cells but also both the proliferation and the differentiation of effector cell precursors to the cytolytic state. Eventually, activated cytotoxic T cells and macrophages with IL-2 receptors can induce lysis of target cells (18, 19) . It has been well-demonstrated (20) that cyclosporin A inhibits the proliferation and the function of T lymphocytes by in hibiting IL-2 production and then suppresses the anti body production and the activation of effector cells, while azathioprine widely inhibits the proliferation of mononuclear cells during the immunoreaction. Accord ingly, it is reasonable to consider that the specific in hibitory action of cyclosporin A against activated mono nuclear cells such as IL-2-positive cells is greater than that of azathioprine. In the present study, the increase in the number of IL-2 recepor-positive cells in the glomeruli had been reduced by OB-5 as well as cyclo sporin A, by the 5th day after the injection of anti GBM serum, while the increase in the number of cyto toxic T cells, macrophages and la-positive cells in the OB-5 treated-group had been reduced by the 15th day. However, OB-5 did not reduce the increase in the num ber of helper T cells in the glomeruli; in contrast, cyc losporin A markedly inhibited it. In addition, 013-5 did not affect the antibody production against rgG through out the experimental period, although the number of IL-2 receptor-positive cells, macrophages and la-posi tive cells was reduced by the treatment with OB-5. These results suggest that OB-5 may directly inhibit only the proliferation of IL-2-positive effector cells or IL-2 receptor expression on the effector cells, such as cytotoxic T cells and macrophages, leading to the re duced cytolytic activity in the glomeruli. It is considered that the inhibitory effect of OB-5 on the immunoreac tion may be quite different from those of cyclosporin A and azathioprine. Moreover, we found that the anti nephritic effect of OB-5 on accelerated passive Heymann nephritis (APHN) was also less than that on crescentic-type nephritis (unpublished data of T. Hat tori et al.). It has been believed that the induction and development of APHN are not mediated by leukocyte infiltration into glomeruli, and it may depend on the antibody formation against heterologous antigens (21, 22) . In addition, we also found that the numbers of cytotoxic T cells, macrophages, la antigen and IL-2 receptor-positive cells in the glomeruli of APHN rats was not higher than those of normal rats. These results further support our speculation regarding the mecha nisms of the antinephritic effect of OB-5 on crescentic type anti-GBM nephritis.
